Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 09/30 04:56:48 pm
89.1 USD   -0.50%
09/29 CVS HEALTH : Expands Access to Opioid Overdose-Reversal Drug for CVS..
09/29 CVS HEALTH : slated for Fraser Centre Target store
09/29 CVS HEALTH : Our Supplier Diversity Program is Keeping Pace with Cha..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

CVS Caremark Corporation : U.S. asks CVS about its prescription discount plan

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2012 | 10:28pm CEST

CVS Caremark Corp said it received requests for information about a prescription drug discount program it runs for uninsured or under-insured individuals from both the U.S. government and the Texas Attorney General.

In January, CVS received a subpoena from the U.S. Office of Inspector General requesting information about the company's Health Savings Pass program, CVS said in its 10k filing on Friday.

The company, which runs the CVS pharmacy chain and the CVS Caremark pharmacy benefits management service, said the request was connected to an investigation of possible false or otherwise improper claims for payment involving Health & Human Services programs.

In February, CVS received a civil investigative demand from Texas' Office of the Attorney General. That office requested a copy of information from the OIG subpoena and other information related to prescription drug claims submitted by CVS pharmacies to Texas Medicaid for reimbursement, the company said.

CVS said it would respond to the requests for information and cooperate with both investigations.

CVS markets its Health Savings Pass, which has a $15 annual fee, to people who do not have prescription drug coverage and to those who have limited coverage.

The Health Savings Pass lets patients fill 90-day prescriptions for 400 generic drugs for $11.99. Participants also get discounts such as 10 percent off visits at the CVS in-store health clinic, MinuteClinic and 10 percent off an annual flu shot.

The announcement comes about a month after CVS agreed to pay $5 million to settle charges of inaccurate pricing of some drugs for the elderly and disabled, ending a wide-ranging, multi-year probe into its business practices.

Shares of CVS closed down 28 cents at $44.27, after reaching a new high of $45 earlier in the day.

(Reporting by Jessica Wohl in Chicago; Editing by Richard Chang)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
09/29 CVS HEALTH : Expands Youth Drug Abuse Prevention Efforts for the 2016-2017 Schoo..
09/29 CVS HEALTH : Expands Access to Opioid Overdose-Reversal Drug for CVS Pharmacy Pa..
09/29 CVS HEALTH : slated for Fraser Centre Target store
09/29 CVS HEALTH : Our Supplier Diversity Program is Keeping Pace with Change
09/25 PHARMACY SHUTDOWNS : Independent businesses being swallowed up by falling reimbu..
09/22 DAILY DIVIDEND REPORT : Lmt, idcc, safm, cvs, len
09/22 CVS HEALTH CORPORATION : Announces Quarterly Dividend
09/22 CVS HEALTH : The First Tobacco-Free Generation Is Within Reach
09/22 CVS HEALTH : to offer curbside pickup in Chicago area
09/19 CVS HEALTH : Expands Youth Drug Abuse Prevention Efforts for the 2016-2017 Schoo..
More news
Sector news : Drug Retailers - NEC
12:38pDJJ SAINSBURY : Sainsbury Appoints Walgreens Boots' Simon Roberts As Retail Direct..
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/14DJGoogle Acquisition Apigee's Revenue Climbs
More sector news : Drug Retailers - NEC
News from SeekingAlpha
09/29 Buying Dividend Growth Stocks Without Looking; 17 Months Later.
09/28 PE firms snooze on 650-unit Walgreens sale
09/27 Top 10 Growth Stocks From The Dividend Contenders List
09/27 My 85 Stock Portfolio Evaluation Of Want To Buy Prices And Yields For Purchas..
09/25 PORTFOLIO PURCHASES : Adding 3 Companies With More Than 15% Upside To Our Divide..
Advertisement
Financials ($)
Sales 2016 179 864 M
EBIT 2016 10 786 M
Net income 2016 5 715 M
Debt 2016 24 998 M
Yield 2016 1,82%
P/E ratio 2016 17,30
P/E ratio 2017 14,38
EV / Sales 2016 0,67x
EV / Sales 2017 0,61x
Capitalization 95 480 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 111 $
Spread / Average Target 24%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-8.41%95 480
WALGREENS BOOTS ALLIAN..-6.98%85 730
EXPRESS SCRIPTS HOLDIN..-20.10%44 014
MCKESSON CORPORATION-16.64%37 110
CARDINAL HEALTH INC-13.86%24 604
AMERISOURCEBERGEN CORP..-21.66%19 329
More Results